GAF Healthcare
Specialty Overview

Best Hospitals for Nasopharyngeal Cancer Treatment in Mumbai, India

18 cancer care hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,622 beds combined.

18
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the cancer care hospitals in our directory offering Nasopharyngeal Cancer Treatment in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Nanavati Super Specialty Hospital🇮🇳 Kokilaben Dhirubhai Ambani Hospital🇮🇳 Tata Memorial Hospital

Ask us about nasopharyngeal cancer treatment in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 18 accredited hospitals for Cancer Care in Mumbai, India

Nanavati Super Specialty Hospital Featured
Starting from$1,000

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Enquire NowView Profile
Kokilaben Dhirubhai Ambani Hospital
Starting from$1,000

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Enquire NowView Profile
Tata Memorial Hospital
Starting from$1,000

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Enquire NowView Profile
Apollo Hospitals, Navi Mumbai
Starting from$1,000

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Enquire NowView Profile
Gleneagles Hospital, Mumbai
Starting from$1,000

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviewsAccredited by JCI, NABH638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Enquire NowView Profile
Lilavati Hospital And Research Centre
Starting from$1,000

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviewsAccredited by JCI, NABH326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Enquire NowView Profile
HCG Cancer Centre
Starting from$1,000

🇮🇳 HCG Cancer Centre

Mumbai, India 4.6 (91 reviews) 119 beds
Why consider this hospital?
4.6/5 rating from 91 reviewsAccredited by NABH, NABL119 beds
Specialties & Accreditation
OncologyRadiation TherapySurgical OncologyHematologyNuclear Medicine
Accredited by NABH, NABL

Patients considering nasopharyngeal cancer treatment can be cared for by HCG Cancer Centre's care team in Mumbai, India, from initial consultation through recovery. HCG Cancer Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.6/5
Rating
1998
Established
119
Beds
Mumbai, India
Location
Enquire NowView Profile
Jaslok Hospital
Starting from$1,000

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviewsAccredited by NABH, NABL350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Accredited by NABH, NABL

Patients considering nasopharyngeal cancer treatment can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Enquire NowView Profile
Gleneagles Global Hospitals (Global Hospitals)
Starting from$1,000

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviewsAccredited by NABH, JCI450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Accredited by NABH, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Enquire NowView Profile
Medicover Hospital, Navi Mumbai
Starting from$1,000

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviewsAccredited by NABH310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Accredited by NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Nasopharyngeal Cancer Treatment in Mumbai, India?

Choosing the right hospital for nasopharyngeal cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cancer care rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Nasopharyngeal Cancer Treatment

Nasopharyngeal cancer (NPC) is a malignancy arising from the epithelial lining of the nasopharynx, requiring a highly specialized multimodal approach combining intensity-modulated radiation therapy (IMRT), platinum-based chemotherapy, and—where indicated—targeted or immunotherapy agents.

7–21 days (varies by treatment phase: induction chemotherapy admissions average 3–5 days per cycle; concurrent chemoradiation is largely outpatient but may require 7–14 days of inpatient monitoring for toxicity management)
Hospital Stay
6–8 weeks (after completion of the primary chemoradiation course, patients typically require 4–6 weeks of local recovery and acute toxicity resolution before they are cleared for long-haul international flight; patients undergoing adjuvant immunotherapy may need to remain in-country for up to 8 weeks for the initial cycles)
Total Stay in Country (Fit-to-Fly)
72–90% (five-year overall survival for Stage I–III locoregional NPC; Stage I approaches 90%+; Stage IVA/B approximately 65–72% with modern chemoimmunotherapy protocols)
Success Rate

Clinical Overview

  • Nasopharyngeal carcinoma originates in the mucosal epithelium of the nasopharynx, the air-filled space behind the nasal cavity at the skull base.
  • The World Health Organization classifies NPC into three histological subtypes: Type I (keratinizing squamous cell carcinoma), Type II (non-keratinizing differentiated), and Type III (undifferentiated or lymphoepithelioma-like), with Type III being the most prevalent globally and most strongly associated with Epstein-Barr virus (EBV) infection.
  • Because the nasopharynx is anatomically adjacent to critical structures—the cavernous sinus, cranial nerves III through VI, the internal carotid artery, and the cervical lymphatic chains—tumor extension can cause epistaxis, unilateral serous otitis media, cranial nerve palsies, trismus, and cervical lymphadenopathy.
Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS:
  • Histologically confirmed NPC (biopsy of primary lesion or involved lymph node with pathology review)
  • Any AJCC 8th Edition stage (Stage I through IVB) considered for curative-intent treatment; Stage IVC (distant metastatic) considered for palliative or systemic intent
  • ECOG Performance Status 0–2 (adequate functional reserve for chemoradiation or systemic therapy)
  • +20 more

Treatment Options & Approaches

  • STANDARD CURATIVE-INTENT CHEMORADIATION (Stage II–IVB): The backbone of NPC treatment is concurrent cisplatin (40 mg/m² weekly or 100 mg/m² every 3 weeks) combined with intensity-modulated radiation therapy (IMRT) delivering 70 Gy in 33–35 fractions to the gross tumor volume (GTV), with sequential dose painting to elective nodal regions at 54–63 Gy.
  • Daily IGRT (cone-beam CT verification) ensures sub-millimeter positioning accuracy critical at the skull base.
  • Volumetric-modulated arc therapy (VMAT) is a widely used IMRT delivery technique that reduces treatment time per fraction while maintaining dosimetric precision.

Recovery

  • PRE-ARRIVAL (2–4 WEEKS BEFORE DEPARTURE):

Risks to be aware of

  • Nasopharyngeal cancer treatment carries a well-characterized spectrum of acute and late toxicities that patients must understand prior to initiating therapy.
  • Acute toxicities during chemoradiation include Grade 3–4 oral mucositis (occurring in 40–70% of patients), severe dysphagia requiring temporary enteral nutrition (20–40%), radiation dermatitis of the face and neck, nephrotoxicity and hypomagnesemia from cisplatin (requiring vigilant renal monitoring and electrolyte replacement), myelosuppression (requiring growth factor support and dose modifications), and fatigue.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, non-medical support system designed to eliminate logistical friction for international NPC patients and their families throughout the treatment journey.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Nasopharyngeal Cancer Treatment

What is the cost of Nasopharyngeal Cancer Treatment in India compared to the UAE?
The total cost of a complete nasopharyngeal cancer treatment program—including induction chemotherapy (if indicated), concurrent chemoradiation (IMRT + cisplatin-based chemotherapy), all inpatient admissions, standard supportive medications, and routine monitoring investigations—typically ranges from $7,000 to $18,000 USD at top NABH- and JCI-accredited centers in India (including institutions such as Tata Memorial Hospital Mumbai, Apollo Proton Cancer Centre Chennai, Rajiv Gandhi Cancer Institute New Delhi, and Fortis Memorial Research Institute Gurgaon). The equivalent program at JCI- and DHA/DOH-accredited hospitals in the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai, American Hospital Dubai) typically ranges from $18,000 to $42,000 USD—reflecting premium infrastructure, luxury patient experience, and higher operational costs. India is therefore approximately 55–65% less expensive than the UAE for equivalent clinical protocols. Both destinations deliver the same evidence-based treatment standards (NCCN/ESMO-aligned IMRT + cisplatin-based chemoradiation, plasma EBV DNA monitoring, MDT tumor board evaluation). If proton beam therapy is required—available at Apollo Proton Cancer Centre in Chennai and select UAE facilities—add approximately $15,000–$25,000 (India) or $30,000–$50,000 (UAE) to these base costs. GAF Healthcare provides itemized, all-inclusive cost estimates within 48–72 hours of receiving the patient's staging reports, with no hidden charges.
How long do I need to stay in the country before I am fit to fly home after Nasopharyngeal Cancer Treatment?
The minimum recommended in-country stay before international flight clearance is 6 to 8 weeks after completion of the primary concurrent chemoradiation course. A full NPC treatment program (induction chemotherapy + concurrent chemoradiation) requires approximately 12–15 weeks in-country if all phases are completed consecutively. Here is a practical breakdown: Induction chemotherapy alone (3 cycles of gemcitabine-cisplatin, if indicated) requires approximately 7–8 weeks in-country per phase, with short returns home possible between cycles if the patient's home-country oncologist can administer subsequent cycles. The concurrent chemoradiation phase (7 weeks of daily radiation, Monday–Friday) is continuous and cannot be interrupted; patients must remain in-country for the full duration. After the last radiation fraction, patients typically require a further 4–6 weeks of local recovery before acute toxicities (mucositis, dysphagia, fatigue) resolve sufficiently for safe air travel. At the 6-week post-CCRT mark, the treating team performs clinical review and, where appropriate, initial response MRI or plasma EBV DNA assessment. Fit-to-fly clearance is issued individually based on: (a) absence of uncontrolled acute toxicity, (b) adequate oral or enteral nutritional status, (c) no active infection or unresolved hematological suppression, and (d) no clinical evidence of rapid disease progression requiring immediate intervention. Patients commencing adjuvant immunotherapy (PD-1 inhibitors, 3-weekly cycles) should remain for the first 1–2 cycles to ensure no severe immune-related adverse events (irAEs) before traveling. GAF Healthcare coordinates all fit-to-fly assessments and provides formal medical documentation for airline travel insurance claims and airline medical clearance processes.
What is the success rate of Nasopharyngeal Cancer Treatment?
Nasopharyngeal carcinoma is one of the more treatment-responsive head and neck cancers, particularly for locoregional disease, owing to its high radiosensitivity and—in EBV-positive cases—sensitivity to immunotherapy. Five-year overall survival rates by AJCC 8th Edition stage, based on contemporary IMRT-era data from high-volume centers, are as follows: Stage I: approximately 90–95%; Stage II: approximately 85–90%; Stage III: approximately 78–85%; Stage IVA (T4 or N3, non-metastatic): approximately 65–75%; Stage IVB (M1, distant metastatic): approximately 30–40% at 3 years with modern chemoimmunotherapy (gemcitabine-cisplatin + camrelizumab or tislelizumab, per CAPTAIN-1 and JUPITER-02 trial data). Plasma EBV DNA clearance at week 8–12 post-CCRT is the strongest validated prognostic biomarker: patients achieving undetectable EBV DNA have a 3-year failure-free survival exceeding 88%, compared to approximately 47% for those with persistent EBV DNA elevation (Sun et al., NEJM 2023). At GAF Healthcare's partner institutions—which include centers with annual NPC case volumes exceeding 200–400 new patients—outcomes are consistent with or superior to these published benchmarks due to case volume, protocol standardization, and dedicated skull base oncology MDT structures. The success of treatment also depends on consistent follow-up surveillance, which GAF Healthcare facilitates remotely after the patient returns home through telemedicine and coordinated reporting with the local oncologist.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Nasopharyngeal Cancer Treatment in Mumbai, India

Discover the Top Hospitals for Nasopharyngeal Cancer Treatment in Mumbai, India

This page lists 18 accredited cancer care hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about nasopharyngeal cancer treatment in Mumbai, India

How many cancer care hospitals are listed in Mumbai, India?
18 hospitals in our Mumbai, India directory are currently listed for cancer care including Nasopharyngeal Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cancer care hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for nasopharyngeal cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about nasopharyngeal cancer treatment in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for nasopharyngeal cancer treatment in Mumbai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us